Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Looks To Expand OTC Reach With CNS Brands

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline will pay nearly five times CNS's 12-month sales total to widen its consumer reach with the acquisition of CNS, the Minneapolis-based maker of Breathe Right and FiberChoice products
Advertisement

Related Content

GSK Leverages Higher Return On OTC R&D Investment To Drive Growth – Witty
GSK Leverages Higher Return On OTC R&D Investment To Drive Growth – Witty
GSK Leverages Higher Return On OTC R&D Investment To Drive Growth – Witty
GSK Touts Alli As Tip Of OTC Strength, Reaffirms Consumer Commitment
GSK Touts Alli As Tip Of OTC Strength, Reaffirms Consumer Commitment
Key OTC Acquisitions Boost GSK’s Q1 Consumer Health Care Sales
J&J, Pfizer Satisfy FTC Conditions To Clear Deal; EC Signs Off
GSK Merger Helps CNS Breathe Easier About Breathe Right Patent Expiration
Pfizer Weighs Options For OTC Division As Investors Line Up For Purchase
Pfizer Weighs Options For OTC Division As Investors Line Up For Purchase

Topics

Advertisement
UsernamePublicRestriction

Register

PS099849

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel